Observational study on Guillain-Barre Syndrome at a single center
Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome (FOCUS on GBS)
This study looks at the experiences of adults with Guillain-Barre Syndrome over the last 15 years to see how often it occurs, what symptoms they have, and how different treatments affect their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 1 site (Basel) |
| Trial ID | NCT04829526 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze data from adult patients diagnosed with Guillain-Barre Syndrome (GBS) at the University Hospital of Basel over the past 15 years. It focuses on understanding the frequency, clinical and electrophysiologic characteristics, complications, treatment regimes, and their associations with disease courses and outcomes. By collecting and reviewing patient data, the study seeks to provide insights into the management and prognosis of GBS.
Who should consider this trial
Good fit: Ideal candidates are adults with a suspected or proven diagnosis of Guillain-Barre Syndrome who were treated at the University Hospital of Basel between January 2005 and February 2021.
Not a fit: Patients who have refused general consent for participation will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of GBS, leading to improved diagnostic and treatment strategies for patients.
How similar studies have performed: While this study is observational and retrospective, similar studies have provided valuable insights into GBS management, suggesting potential for meaningful findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * suspected diagnosis of GBS, who have been treated at the University Hospital of Basel from 01.01.2005-28.02.2021 Exclusion Criteria: * Patients with documented refusal of the general consent.
Where this trial is running
Basel
- Clinic for Intensive Care Medicine; University Hospital Basel — Basel, Switzerland (Recruiting)
Study contacts
- Principal investigator: Raoul Sutter, Prof. Dr. med. — Clinic for Intensive Care Medicine, University Hospital Basel
- Study coordinator: Raoul Sutter, Prof. Dr. med.
- Email: raoul.sutter@usb.ch
- Phone: +41 61 32 87 928
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.